3.18

11.19% 0.32

Pre-market: 3.17 -0.01 -0.31%

Allurion Technologies Inc (ALUR)

Overview News Price History Option Chain Discussions Forecast

Allurion Technologies Inc stock is traded at $3.18, with a volume of 192.24K. It is up +11.19% in the last 24 hours and up +28.23% over the past month. Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Previous Close:

$2.86

Open:

$2.89

24h Volume:

192.24K

Relative Volume:

0.60

Market Cap:

$23.72M

Revenue:

$34.75M

Net Income/Loss:

$-24.76M

P/E Ratio:

-0.265

EPS:

-12

Net Cash Flow:

$-50.91M

1W Performance:

+22.78%

1M Performance:

+28.23%

6M Performance:

-10.92%

1Y Performance:

-87.28%

1-Day Range:

$2.8721

$3.18

1-Week Range:

$2.60

$3.18

52-Week Range:

$2.15

$25.50

Allurion Technologies Inc Stock (ALUR) Company Profile

Name

Allurion Technologies Inc

Sector

Healthcare (1169)

Industry

Medical Devices (147)

Phone

508-647-4000

Address

11 HURON DR STE 200, NATICK

Employee

137

Twitter

Next Earnings Date

2024-12-13

Latest SEC Filings

ALUR's Discussions on Twitter

Compare ALUR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALUR Allurion Technologies Inc	3.18	19.32M	34.75M	-24.76M	-50.91M	-12.00
ABT Abbott Laboratories	131.49	232.02B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	103.48	151.51B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	390.59	148.85B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	89.22	113.49B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	76.81	44.81B	5.54B	4.18B	623.10M	7.00

Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Downgrade	Chardan Capital Markets	Buy → Neutral
Oct-02-24	Initiated	TD Cowen	Buy
Sep-06-24	Initiated	ROTH MKM	Buy
Feb-09-24	Initiated	Jefferies	Buy

Allurion Technologies Inc Stock (ALUR) Latest News

Jul 15, 2025

Why Allurion Technologies Inc. stock attracts strong analyst attentionSmart Money Signals - Newser

Jul 15, 2025

What makes Allurion Technologies Inc. stock price move sharplyVerified Chart Patterns - Newser

Jul 15, 2025

How Allurion Technologies Inc. stock performs during market volatilitySmart Money Signals - Newser

Jul 15, 2025

Why Allurion Technologies Inc. Equity Warrant stock attracts strong analyst attentionHigh Potential Shares - Newser

Jul 15, 2025

How Allurion Technologies Inc. Equity Warrant stock performs during market volatilityHigh Potential Stock Ideas - Newser

Jul 15, 2025

What makes Allurion Technologies Inc. Equity Warrant stock price move sharplyMinimized Risk Maximum Return - Newser

Jul 15, 2025

Jul 10, 2025

Allurion Technologies stock rises on Canadian distribution partnership By Investing.com - Investing.com South Africa

Jul 10, 2025

Allurion Technologies stock rises on Canadian distribution partnership - Investing.com

Jul 10, 2025

Jul 09, 2025

Allurion partners with Minogue Medical to expand weight loss program in Canada By Investing.com - Investing.com South Africa

Jul 09, 2025

Allurion Forms Distribution Partnership with Minogue Medical in Canada - MarketScreener

Jul 09, 2025

Allurion Technologies announces distribution partnership with Minogue - TipRanks

Jul 09, 2025

Allurion partners with Minogue Medical to expand weight loss program in Canada - Investing.com

Jul 09, 2025

Allurion Expands Metabolic Weight Loss Program to Canadian Market | ALUR Stock News - Stock Titan

Jul 09, 2025

Jul 07, 2025

Allurion submits final PMA module for weight loss balloon to FDA - Investing.com Canada

Jul 07, 2025

Allurion submits final PMA module for weight loss balloon to FDA By Investing.com - Investing.com South Africa

Jul 07, 2025

Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints - Yahoo Finance

Jul 07, 2025

Allurion's Revolutionary Weight Loss Balloon Achieves 4.34% Superior Weight Loss in Pivotal FDA Trial - Stock Titan

Jul 07, 2025

Jun 17, 2025

Major Weight Loss Breakthrough: 20,000 Patient Study Reveals Muscle-Preserving Success of Allurion Program - Stock Titan

Jun 17, 2025

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS - New Castle News

Jun 17, 2025

Jun 16, 2025

Allurion Technologies Inc. (NYSE:ALUR) Short Interest Down 42.4% in May - Defense World

Jun 16, 2025

Jun 11, 2025

(ALUR) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 11, 2025

Jun 10, 2025

Allurion Technologies (NYSE:ALUR) Trading 2.1% Higher – Time to Buy? - Defense World

Jun 10, 2025

Jun 04, 2025

Allurion at Jefferies Conference: Strategic US Market Entry By Investing.com - Investing.com South Africa

Jun 04, 2025

Allurion at Jefferies Conference: Strategic US Market Entry - Investing.com Australia

Jun 04, 2025

May 29, 2025

October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - The Globe and Mail

May 29, 2025

Weight Loss Pioneer Allurion Takes Center Stage at Major Jefferies Healthcare Conference - Stock Titan

May 29, 2025

May 28, 2025